175 related articles for article (PubMed ID: 35478939)
21. Comprehensive Analysis of the Role of
Chu M; Zheng K; Li X; Luo Z; Yang X; Wei C
Anal Cell Pathol (Amst); 2022; 2022():2371057. PubMed ID: 36247875
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
23. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
24. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
25. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
[TBL] [Abstract][Full Text] [Related]
27. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
[TBL] [Abstract][Full Text] [Related]
29. MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
Xing J; Gu Y; Song Y; Liu Q; Chen Q; Han P; Shen Z; Li H; Zhang S; Bai Y; Ma J; Sui F
BMC Cancer; 2023 Dec; 23(1):1267. PubMed ID: 38129784
[TBL] [Abstract][Full Text] [Related]
30. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
31. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
33. TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis.
He R; Zhang X; Wu Y; Weng Z; Li L
Cancer Med; 2023 Dec; 12(24):22354-22369. PubMed ID: 37990988
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
35. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis.
Ding Y; Li M; Tayier T; Chen L; Feng S
Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinoma.
Gopalakrishnan KV; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101617. PubMed ID: 37666484
[TBL] [Abstract][Full Text] [Related]
37. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of HIST1H2BH in head and neck squamous cell carcinoma].
Wang SP; Ding ZX; Meng J; Li M; Li XD; Yuan Z
Shanghai Kou Qiang Yi Xue; 2021 Dec; 30(6):599-605. PubMed ID: 35587014
[TBL] [Abstract][Full Text] [Related]
40. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
